Cargando…

Letter to editor in response to: Comparison of diagnostic accuracy between endometrial curettage and aspiration biopsy in patients treated with progestin for endometrial hyperplasia: a Korean Gynecologic Oncology Group study

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2020
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7440986/ https://www.ncbi.nlm.nih.gov/pubmed/32808506 http://dx.doi.org/10.3802/jgo.2020.31.e88

Ejemplares similares

Response to comment on: Comparison of diagnostic accuracy between endometrial curettage and aspiration biopsy in patients treated with progestin for endometrial hyperplasia: a Korean Gynecologic Oncology Group study
Publicado: (2020)

Comparison of diagnostic accuracy between endometrial curettage and aspiration biopsy in patients treated with progestin for endometrial hyperplasia: a Korean Gynecologic Oncology Group study
por: Kim, Mi Kyoung, et al.
Publicado: (2020)

Aspiration biopsy versus dilatation and curettage for endometrial hyperplasia prior to hysterectomy
por: Hwang, Woo Yeon, et al.
Publicado: (2021)

Dilatation and curettage is more accurate than endometrial aspiration biopsy in early-stage endometrial cancer patients treated with high dose oral progestin and levonorgestrel intrauterine system
por: Kim, Da Hee, et al.
Publicado: (2017)

Progestin Resistance and Corresponding Management of Abnormal Endometrial Hyperplasia and Endometrial Carcinoma
por: Lv, Mu, et al.
Publicado: (2022)

Progestin Intrauterine Devices and Metformin: Endometrial Hyperplasia and Early Stage Endometrial Cancer Medical Management
por: Nwanodi, Oroma
Publicado: (2017)

Progestin plus metformin improves outcomes in patients with endometrial hyperplasia and early endometrial cancer more than progestin alone: a meta-analysis
por: Shao, Fengping, et al.
Publicado: (2023)

Endometrial aspiration cytology in gynecological disorders
por: Jadhav, Meenal V., et al.
Publicado: (2016)

Identification of Genes and Pathways Differentially Expressed in Progestin Responsive Endometrial Cancer and Hyperplasia
por: Gertz, Jay, et al.
Publicado: (2021)

Long-term outcomes of progestin plus metformin as a fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer patients
por: Mitsuhashi, Akira, et al.
Publicado: (2019)

Dilatation and Curettage Effect on the Endometrial Thickness
por: Davar, Robab, et al.
Publicado: (2013)

Trends and characteristics of fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer in Japan: a survey by the Gynecologic Oncology Committee of the Japan Society of Obstetrics and Gynecology
por: Ushijima, Kimio, et al.
Publicado: (2023)

Controversies in the management of endometrial cancer: a survey of the Korean Gynecologic Oncology Group
por: Lee, Jung-Yun, et al.
Publicado: (2015)

Hysteroscopic endometrial biopsy with immunohistochemistry in the diagnosis of endometritis
por: Zhang, Yan, et al.
Publicado: (2021)

Risk factor analysis of coexisting endometrial carcinoma in patients with endometrial hyperplasia: a retrospective observational study of Taiwanese Gynecologic Oncology Group
por: Chen, Yu-Li, et al.
Publicado: (2013)

Fallopian Tube Carcinoma In-situ in Endometrial Curettage
por: Nishith, Nilay, et al.
Publicado: (2018)

Manual vacuum aspiration (women's MVA) for endometrial biopsy for patients with suspected endometrial malignancies
por: Saito, Etsuko, et al.
Publicado: (2022)

Fertility-preserving treatment in complex atypical hyperplasia and early endometrial cancer in young women with oral progestin: Is it effective?
por: Baek, Ji Sun, et al.
Publicado: (2016)

Diagnostic Accuracy of Hysteroscopic Scoring System in Predicting Endometrial Malignancy and Atypical Endometrial Hyperplasia
por: Harika, Bhukya, et al.
Publicado: (2021)

Identification of potential models for predicting progestin insensitivity in patients with endometrial atypical hyperplasia and endometrioid endometrial cancer based on ATAC-Seq and RNA-Seq integrated analysis
por: Hu, Jia-Li, et al.
Publicado: (2022)

Microscale endometrial sampling biopsy in detecting endometrial cancer and atypical hyperplasia in a population of 1551 women: a comparative study with hysteroscopic endometrial biopsy
por: Zhang, Guo, et al.
Publicado: (2021)

Hysteroscopic Curettage Followed by Megestrol Acetate Plus Metformin as a Fertility-Sparing Treatment for Women with Atypical Endometrial Hyperplasia or Well-Differentiated Endometrioid Endometrial Carcinoma
por: Jing, Chu-Yu, et al.
Publicado: (2022)

Prognostic factors of oncologic outcomes after fertility-preservative management with progestin in early-stage of endometrial cancer
por: Roh, Hyun Jin, et al.
Publicado: (2021)

Impact of endometrial sampling technique and biopsy volume on the diagnostic accuracy of endometrial cancer
por: Ferrari, Federico, et al.
Publicado: (2020)

HE4 is a novel tissue marker for therapy response and progestin resistance in medium- and low-risk endometrial hyperplasia
por: Ørbo, Anne, et al.
Publicado: (2016)

HE4 is a novel tissue marker for therapy response and progestin resistance in medium- and low-risk endometrial hyperplasia
por: Ørbo, Anne, et al.
Publicado: (2016)

Diagnostic Accuracy of Liquid Biopsy in Endometrial Cancer
por: Łukasiewicz, Marta, et al.
Publicado: (2021)

Endometrial cancer arising from atypical complex hyperplasia: The significance in an endometrial biopsy and a diagnostic challenge
por: Byun, Jung Mi, et al.
Publicado: (2015)

CD44 expression in curettage and postoperative specimens of endometrial cancer
por: Wojciechowski, Michał, et al.
Publicado: (2014)

Pregnancy Rates after Hysteroscopic Endometrial Polypectomy versus Endometrial Curettage Polypectomy: A Retrospective Study
por: Nishioka, Mikiko, et al.
Publicado: (2023)

Prominent decidualization following progestin treatment for endometrial hyperplasia and carcinoma as a mimic of large residual tumor: A cautionary tale
por: Hu, Yang, et al.
Publicado: (2021)

Characteristics of progestin-insensitive early stage endometrial cancer and atypical hyperplasia patients receiving second-line fertility-sparing treatment
por: Zhou, Shuang, et al.
Publicado: (2021)

Efficacy of Oral Medications or Intrauterine Device-Delivered Progestin in Patients with Endometrial Hyperplasia with or without Atypia: A Network Meta-Analysis
por: Zhang, Yu-Fei, et al.
Publicado: (2023)

Detection of endometrial precancer by a targeted gynecologic cancer liquid biopsy
por: Martignetti, John A., et al.
Publicado: (2018)

Endometrial hyperplasia as a risk factor of endometrial cancer
por: Nees, Lisa K., et al.
Publicado: (2022)

Endometrial biopsy under direct hysteroscopic visualisation versus blind endometrial sampling for the diagnosis of endometrial hyperplasia and cancer: Systematic review and meta-analysis
por: Di Spiezio Sardo, A, et al.
Publicado: (2022)

Letter to the Editor
por: Dharmadhikari, Ashwin S., et al.
Publicado: (2011)

Letter to Editor
por: Şahan, Ekrem, et al.
Publicado: (2017)

Letter to the Editor
por: Goldsborough, Sarah
Publicado: (2018)

Letter to Editor
por: Saks, Michael J.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5mavk0oq39e6am6kudq55l9vcj